Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof

Details for Australian Patent Application No. 2004293435 (hide)

Owner Bristol-Myers Squibb Pharma Company

Inventors Yule, Robert E.; McNulty, Kenneth C.; Pesti, Jaan A.; Sherbine, James P.; Pack, Shawn K.

Agent Callinan

Pub. Number AU-A-2004293435

PCT Pub. Number WO2005/051954

Priority 10/985,236 10.11.04 US; 60/525,050 25.11.03 US

Filing date 19 November 2004

Wipo publication date 9 June 2005

International Classifications

C07D 231/38 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

25 May 2006 PCT application entered the National Phase

  PCT publication WO2005/051954 Priority application(s): WO2005/051954

6 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004293436-Heterocyclic inhibitors of MEK and methods of use thereof

2004293430-Lockable container with integral internal tray